Studies the molecular causes of frontotemporal dementia, amyotrophic lateral sclerosis, Alzheimer's disease, and related neurodegenerative disorders.

Combines cell and animal models, human iPSC systems, proteomics, chemical biology, and high-throughput screening to investigate progranulin and other disease pathways and identify therapeutic targets.